BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 20034828)

  • 1. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source.
    Granero D; Pérez-Calatayud J; Ballester F
    Radiother Oncol; 2005 Jul; 76(1):79-85. PubMed ID: 16019091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dosimetric parameters for various 192Ir brachytherapy sources under unbounded phantom geometry by Monte Carlo simulation.
    Devan K; Aruna P; Manigandan D; Bharanidharan G; Subbaiah KV; Sunny CS; Ganesan S
    Med Dosim; 2007; 32(4):305-15. PubMed ID: 17980833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
    Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
    Sadeghi M; Hamed Hosseini S
    Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IPEM code of practice for determination of the reference air kerma rate for HDR (192)Ir brachytherapy sources based on the NPL air kerma standard.
    Bidmead AM; Sander T; Locks SM; Lee CD; Aird EG; Nutbrown RF; Flynn A;
    Phys Med Biol; 2010 Jun; 55(11):3145-59. PubMed ID: 20479510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric characterization of the (60)Co BEBIG Co0.A86 high dose rate brachytherapy source using PENELOPE.
    Guerrero R; Almansa JF; Torres J; Lallena AM
    Phys Med; 2014 Dec; 30(8):960-7. PubMed ID: 25047841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study.
    Price MJ; Horton JL; Gifford KA; Eifel PJ; Jhingran A; Lawyer AA; Berner PA; Mourtada F
    Phys Med Biol; 2005 Nov; 50(21):5075-87. PubMed ID: 16237242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo dosimetry of the VariSource high dose rate 192Ir source.
    Wang R; Sloboda RS
    Med Phys; 1998 Apr; 25(4):415-23. PubMed ID: 9571607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric parameters estimation using PENELOPE Monte-Carlo simulation code: Model 6711 a 125I brachytherapy seed.
    Rodríguez EA; Alcón EP; Rodriguez ML; Gutt F; de Almeida CE
    Appl Radiat Isot; 2005 Jul; 63(1):41-8. PubMed ID: 15866446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source.
    Chandola RM; Tiwari S; Kowar MK; Choudhary V
    J Cancer Res Ther; 2010; 6(4):421-6. PubMed ID: 21358074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo dosimetric study of the medium dose rate CSM40 source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    Appl Radiat Isot; 2013 Dec; 82():283-8. PubMed ID: 24121444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.